BioSpace News Archive

The global generic injectables market size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period.

The global eClinical Solutions market size is expected to reach USD 15.98 Billion by 2028, registering a CAGR of 13.9% over the forecast period, according to the current analysis of Reports and Data.

Bracco Imaging SpA and BDP International have successfully completed a first-of-its-kind move for the Bracco Group.

The global human liver models market size is expected to reach USD 5.5 Billion by 2028 and register a CAGR of 13.9% over the forecast period, according to the latest report by Reports and Data.

The global occlusion devices market size is expected to reach USD 4.62 Billion in 2028 and register a CAGR of 5.2% over the forecast period, according to the latest report by Reports and Data.

NuGen Medical Devices Inc. is pleased to announce that all matters submitted to shareholders for approval as set out in detail in the Company’s management information circular dated May 17, 2022 were approved at the annual and special meeting of the shareholders of the Company held on June 17, 2022.

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency of single-cell RNA sequencing (scRNA-seq) analysis of rare cell populations.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today announced that on June 17, 2022, it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company is not in compliance with the minimum bid price requirement (“Minimum Bid Requirement”) of US$1.00 per share.

The U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.